Cargando…
The Mechanism of Oxymatrine Targeting miR-27a-3p/PPAR-γ Signaling Pathway through m6A Modification to Regulate the Influence on Hemangioma Stem Cells on Propranolol Resistance
SIMPLE SUMMARY: In this study, the researchers aimed to understand the mechanism behind the resistance of hemangioma stem cells (HemSCs) to propranolol, a commonly used drug for hemangioma treatment. They investigated the role of a specific signaling pathway involving miR-27a-3p and PPAR-γ, as well...
Autores principales: | Dai, Yuxin, Qiu, Mingke, Zhang, Shenglai, Peng, Jingyu, Hou, Xin, Liu, Jie, Li, Feifei, Ou, Jingmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649746/ https://www.ncbi.nlm.nih.gov/pubmed/37958388 http://dx.doi.org/10.3390/cancers15215213 |
Ejemplares similares
-
Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Subglottic Hemangioma Treated With Propranolol
por: Hardison, Scott A., et al.
Publicado: (2014)